IDRI EXECUTIVE LEADERSHIP

Chris Antony
Vice President, Operations

Anna Marie Beckmann, PhD
Sr. Vice President, Development & Regulatory

Doug Bradley, PhD, JD
General Counsel & Secretary

Darrick Carter, PhD
Vice President, Adjuvant Technology

Kim Clary, PhD
Vice President, Alliance Management

Rhea Coler, PhD
Sr. Vice President, Preclinical Biology &Translational Research

Steve Cordial, MBA
Chief Financial Officer

Chris Fox, PhD
Director, Formulations

Tanya Parish, PhD
Vice President, Drug Discovery

Steven G. Reed, PhD
President, CEO & Founder

Dan Stinchcomb, PhD
Sr. Vice President, Vaccine Development and Viral Diseases

Winston Wicomb, PhD, LATG
Director, Vivarium

Thomas Vedvick, PhD
Vice President, Formulation & Process Development

IDRI BOARD OF DIRECTORS

Bruce Carter, PhD, Board Chair
Former President, ZymoGenetics

Gail Cassell, PhD
Visiting Professor, Harvard

Steve Cordial, MBA
Chief Financial Officer, IDRI

Michel De Wilde, PhD
Consultant

Christopher Hentschel, PhD
Partner, Life Science Ventures

Erik Iverson, JD, LLM
Managing Director, Wisconsin Alumni Research Foundation

Franklyn G. Prendergast, MD, PhD
Edmond & Marion Guggenheim Professor of Biochemistry & Molecular Biology
Professor of Molecular Pharmacology & Experimental Therapeutics Mayo Medical School, Emeritus

Massimo Radaelli, PhD
President/Founder, Noventia Pharma/Bioakos

Steven G. Reed, PhD
President, CEO & Founder, IDRI

Kari Stoever
Chief External Officer, Lieber Institute for Brain Development